Sponsor Dossier
Strides Pharma Science
Sponsor Dossier for Strides Pharma Science. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ALDIQ
- Brand: ALINIVIR
- Brand: AMELIA-35
- Brand: AMITRIPTYLINE-STR
- Brand: AMOXAPIN
- Brand: ANASTROZOLE
- Brand: APL-FINASTERIDE
- Brand: ARW
About
Strides Pharma Science is an Australian Private Company with ABN 44635036734, registered in NSW and currently active.
Portfolio
Strides Pharma Science has 119 brands on the ARTG, of which 37 are indexable and 33 carry a Product Information document. 17 brands are PBS-listed, 0 have a PBAC outcome on record, and 0 have an AusPAR on record. Notable brands include ALDIQ, ALINIVIR, AMELIA-35, AMITRIPTYLINE-STR, AMOXAPIN, ANASTROZOLE, APL-FINASTERIDE, ARW, ATENOLOL-STR, AURO, AURO-ARIPIPRAZOLE, AURO-CANDESARTAN HCT.
Therapeutic focus
— Infectious Disease: 26 brands — Cardiology: 20 brands — Psychiatry: 18 brands — Neurology: 10 brands — Endocrinology: 9 brands — Oncology: 7 brands — Reproductive Health: 7 brands — Immunology: 6 brands — Gastroenterology: 6 brands — Musculoskeletal: 3 brands — Pain Management: 3 brands — Dermatology: 2 brands — Other: 1 brand — Respiratory: 1 brand
PBS footprint
17 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.